V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10425971 | 10057264 | 1.86 | 0 | null | 2020-01-08 | 2020-02-03 | null | 02 | null | LETROZOLE + PALBOCICLIB | 100173553 |
| 10426008 | 10057265 | 1.86 | 64.4 | Palliative (P) | 2018-08-02 | 2018-08-25 | Pentostatin | 02 | N | ANAGRELIDE | 100681031 |
| 10426029 | 10057266 | 1.68 | 46 | Curative (C) | 2018-12-09 | 2018-12-23 | Gemcitabine + Oxaliplatin | 99 | N | TRASTUZUMAB EMTANSINE | 101147227 |
| 10426041 | 10057267 | null | 88.3 | null | 2019-09-10 | 2020-01-10 | Cyclophos + Dex + Lenalidomide | 02 | null | MERCAPTOPURINE | 101529503 |
| 10426091 | 10057268 | 1.71 | 59.6 | null | 2018-11-08 | 2019-04-30 | Erlotinib | null | null | OXALIPLATIN + RALTITREXED | 100935122 |
| 10426107 | 10057270 | 1.77 | 57.8 | null | 2019-09-09 | 2019-09-27 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 02 | null | ZANUBRUTINIB | 100900217 |
| 10426111 | 10057271 | 0 | 76.6 | null | null | 2019-09-29 | DOCETAXEL + TRASTUZUMAB | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100438363 |
| 10426519 | 10057274 | 1.69 | 59.6 | Adjuvant (A) | 2019-04-25 | 2019-04-25 | EC + DOCETAXEL | N | N | SCALOP-2 TRIAL | 100611995 |
| 10426523 | 10057275 | 1.81 | 77.4 | Palliative (P) | 2018-08-17 | 2018-08-17 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | 02 | N | CYCLOPHOSPHAMIDE + FLUDARABINE | 100706425 |
| 10426726 | 10057276 | null | null | Palliative (P) | null | 2020-01-27 | CAPECITABINE + TEMOZOLOMIDE | 02 | N | CHLORAMBUCIL + RITUXIMAB | 101855539 |
| 10426750 | 10057277 | 1.59 | 68 | null | 2016-08-01 | 2016-08-01 | FEC | 02 | null | CISPLATIN + GEMCITABINE + RITUXIMAB | 101368631 |
| 10426758 | 10057278 | null | null | 03 | 2017-09-30 | 2017-10-01 | null | 02 | N | BENDAMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 101581227 |
| 10426776 | 10057279 | 0 | 70.5 | Palliative (P) | 2017-08-05 | 2017-09-20 | Brentuximab | 02 | N | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE | 101449159 |
| 10426962 | 10057281 | 1.66 | 89.9 | null | 2019-06-11 | 2019-07-15 | CARBOPLATIN + FLUOROURACIL | 01 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100865963 |
| 10426982 | 10057282 | 1.88 | 76.8 | null | 2019-04-01 | 2019-04-08 | Cytarabine Low Dose | 02 | null | CAPECITABINE + MITOMYCIN | 100019271 |
| 10427069 | 10057284 | 1.67 | 66 | null | null | 2018-05-20 | BOSUTINIB | N | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 100499022 |
| 10427505 | 10057286 | 1.7 | 111.1 | Curative (C) | null | 2020-10-12 | VDT-PACE | 02 | N | CISPLATIN + PEMETREXED | 100477650 |
| 10427754 | 10057287 | 1.64 | 58.8 | Palliative (P) | null | 2021-02-14 | null | 02 | N | BLEOMYCIN | 101263695 |
| 10427854 | 10057289 | 1.53 | 77.6 | Palliative (P) | 2019-01-31 | 2019-02-02 | ECarboX | 02 | N | PAZOPANIB | 101579997 |
| 10427912 | 10057290 | 1.65 | 50 | null | 2019-05-01 | 2019-05-01 | Obinutuzumab + Venetoclax | 2 | N | CARFILZOMIB | 101121211 |
| 10427984 | 10057291 | 1.52 | 54.5 | null | 2020-06-10 | 2020-06-11 | DA-EPOCH-R | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100060850 |
| 10428479 | 10057294 | null | 78 | null | 2017-03-31 | 2017-04-04 | Cyclophos + Dex + Lenalidomide | 02 | null | OXALIPLATIN + RALTITREXED | 101214293 |
| 10428617 | 10057295 | 1.87 | 94.3 | Palliative (P) | 2020-06-11 | 2020-06-11 | Epirubicin (weekly) | 02 | N | BELANTAMAB MAFODOTIN | 100631787 |
| 10428679 | 10057296 | 0 | 61.5 | Palliative (P) | 2019-12-03 | 2020-01-01 | Liposomal Doxorubicin (Caelyx) | 02 | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 101572724 |
| 10428755 | 10057299 | 1.59 | 85.8 | 03 | 2019-02-12 | 2019-02-17 | ANAGRELIDE | 02 | N | CHLVPP | 100067689 |
| 10428808 | 10057300 | 1.72 | 81.8 | null | 2018-05-10 | 2018-05-10 | Cytarabine High Dose | 99 | null | FLUOROURACIL + MITOMYCIN | 100456981 |
| 10428829 | 10057301 | null | 86.5 | null | 2018-12-28 | 2019-01-02 | Sunitinib | 2 | null | DOCETAXEL + GEMCITABINE | 101416010 |
| 10428836 | 10057302 | 1.47 | 80.4 | Palliative (P) | 2019-08-02 | 2019-09-15 | Doxorubicin + Olaratumab | 02 | N | CARBOPLATIN + CETUXIMAB + FU | 101381699 |
| 10428839 | 10057303 | 1.76 | 62.85 | null | null | 2019-03-04 | Cyclophos + Dex + Lenalidomide | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101700664 |
| 10428945 | 10057304 | 1.81 | 71.7 | null | 2018-12-30 | 2018-12-31 | Irinotecan 14day | 02 | null | BEVACIZUMAB + OLAPARIB | 100287260 |
| 10429154 | 10057306 | 1.71 | 81.4 | null | 2020-12-08 | 2020-12-30 | Panitumumab | 02 | null | EVEROLIMUS | 100197176 |
| 10429186 | 10057307 | 1.84 | 109 | Curative (C) | 2018-07-27 | 2018-08-05 | AML 18 TRIAL | 02 | null | IDELALISIB + RITUXIMAB | 100345001 |
| 10429245 | 10057310 | 1.64 | 76.4 | null | 2020-04-10 | 2020-05-16 | Binimetinib + Encorafenib | 02 | null | ABEMACICLIB + FULVESTRANT | 101686829 |
| 10429259 | 10057311 | 1.59 | 57.1 | Adjuvant (A) | null | 2019-07-18 | Cladribine (subcut) 5 days | 02 | N | CHOP R | 101488142 |
| 10429313 | 10057313 | 0 | 79.6 | null | 2021-04-01 | 2021-04-03 | BLEOMYCIN | 02 | null | INTERFERON ALFA | 100516871 |
| 10429360 | 10057315 | 0 | 73 | null | 2020-03-17 | 2020-03-18 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | null | TRABECTEDIN | 101389522 |
| 10429362 | 10057316 | 1.5 | 85.4 | Curative (C) | 2019-05-10 | 2020-02-02 | CYCLOPHOSPHAMIDE + LENALIDOMIDE | 02 | N | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101266179 |
| 10429476 | 10057317 | 1.54 | 89.4 | null | 2018-05-30 | 2018-06-28 | BOSUTINIB | 02 | null | FCR | 100699439 |
| 10429547 | 10057318 | 1.77 | 63 | Palliative (P) | 2018-11-25 | 2018-11-25 | null | 02 | N | PANITUMUMAB | 101862473 |
| 10429607 | 10057319 | 1.64 | 61.6 | null | 2018-08-17 | 2019-01-03 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | null | TOPOTECAN | 100469914 |
| 10429639 | 10057320 | 1.86 | 67.4 | 03 | 2019-11-02 | 2019-11-02 | Sunitinib | null | N | AZACITIDINE + VENETOCLAX | 100996160 |
| 10429877 | 10057321 | 1.71 | 94.2 | 03 | 2019-06-01 | 2019-12-06 | Fulvestrant + Palbociclib | 02 | N | DOXORUBICIN + OLARATUMAB | 101260661 |
| 10429983 | 10057323 | 1.8 | 154 | null | 2020-10-20 | 2020-11-02 | GEFITINIB | 02 | null | CAPECITABINE + MITOMYCIN | 100827463 |
| 10430003 | 10057324 | 1.51 | 87 | Curative (C) | 2018-09-08 | 2018-12-17 | GemCarbo Days 1+8 | 02 | Y | OXALIPLATIN + MDG | 100282659 |
| 10430215 | 10057327 | 1.73 | 0 | Palliative (P) | 2018-11-09 | 2018-12-01 | null | N | N | STAMPEDE TRIAL | 100568798 |
| 10430229 | 10057329 | 1.64 | 53.8 | 03 | 2019-02-21 | 2019-03-01 | Doxorubicin + Olaratumab | 02 | N | ISATUXIMAB + POMALIDOMIDE | 100505190 |
| 10430234 | 10057330 | 1.66 | 77.1 | Palliative (P) | 2018-10-21 | 2018-10-21 | Obinutuzumab | 02 | N | MATRIX LYMPHOMA TRIAL | 100028405 |
| 10430429 | 10057333 | 1.65 | 56.9 | Curative (C) | 2021-10-23 | 2021-10-27 | EVEROLIMUS | 01 | Y | TRANSPLANT CARBOPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + PACLITAXEL | 100305062 |
| 10430513 | 10057334 | 1.84 | 61.6 | null | 2018-02-28 | 2018-11-30 | null | N | null | CISPLATIN + FLUOROURACIL | 101149832 |
| 10430640 | 10057335 | 1.75 | 93.7 | null | 2020-11-03 | 2020-11-04 | R Chlorambucil | 02 | null | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100014383 |